$0.433000
-0.01-2.70%
At Close: -
$0.411400
-0.02-4.99%
After Hours: 6:52 PM EDT
15 minutes delayed
Comments
Loading...
BioNexus Gene Lab (NASDAQ:BGLC) Stock, Earnings Estimates, EPS, And Revenue
BioNexus Gene Lab reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 14
EPS
$0.011
Quarterly Revenue
$2M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$9.2M
Analyze the earnings history of BioNexus Gene Lab using advanced sorting and filters.
Data brought to you by Benzinga APIs
BioNexus Gene Lab (BGLC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
BioNexus Gene Lab (BGLC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is BioNexus Gene Lab (NASDAQ:BGLC) reporting earnings?
BioNexus Gene Lab (BGLC) is scheduled to report earnings on November 20, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
What were the latest earnings per share (EPS) for BioNexus Gene Lab (NASDAQ:BGLC)?
The Actual EPS was $0.01, which beat the estimate of $0.00.
What were BioNexus Gene Lab’s (NASDAQ:BGLC) revenues?
The Actual Revenue was $2M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.